The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 3 , Pages 667-676 , September 2010

Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction

Winner of the C. Walton Lillehei Resident Forum at the 89th Annual Meeting of the American Association for Thoracic Surgery, May 10, 2009, Boston, Mass.

Received 5 May 2009 ,Revised 3 December 2009 ,Accepted 28 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported in part by NIH R01 HL072812 (to Y.J.W.), NIH/TSFRE K08 HL072812 (to Y.J.W.), an ISHLT Research Fellowship Grant (to J.R.F. III), and NIH HL07843 (to J.R.F.).

 Disclosures: None.

PII: S0022-5223(10)00024-3

doi: 10.1016/j.jtcvs.2009.12.037

The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 3 , Pages 667-676 , September 2010

Article Tools

* Image Usage & Resolution